BlackRock Health Sciences Trust

Incorporated in Delaware and headquartered in New York, BlackRock Health Sciences Trust is a closed-end equity mutual fund that invests primarily in U.S.-listed healthcare companies. The fund targets publicly traded businesses engaged in researching, developing, manufacturing, distributing, or delivering medical devices, pharmaceuticals, biotechnology products, dental supplies, optical equipment, and related healthcare services. The fund uses the Russell 3000 Healthcare Index as its performance benchmark.

The trust employs an active management strategy that extends beyond traditional equity holdings to include derivative instruments, with a particular emphasis on option writing strategies to generate additional income. This approach allows the fund to pursue total return objectives through both capital appreciation and option premium collection. BlackRock Advisors, LLC manages the fund's portfolio and operational activities.

As a closed-end fund structure with approximately $0.5 billion in assets under management, the trust distributes income regularly to shareholders. The fund maintains broad exposure to the U.S. healthcare sector through its diversified equity portfolio, reflecting the size and scope of companies operating across medical products, pharmaceuticals, biotechnology, and healthcare services industries.